These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8556715

  • 1. Ability of okadaic acid and other protein phosphatase inhibitors to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on hydroperoxide production in mouse epidermis in vivo.
    Newell SW, Perchellet EM, Gao XM, Chen G, Perchellet JP.
    Cancer Lett; 1996 Jan 02; 98(2):241-51. PubMed ID: 8556715
    [Abstract] [Full Text] [Related]

  • 2. Ability of the non-phorbol ester-type tumor-promoter thapsigargin to mimic the stimulatory effects of 12-0-tetradecanoylphorbol-13-acetate on ornithine decarboxylase activity, hydroperoxide production, and macromolecule synthesis in mouse epidermis in vivo.
    Perchellet EM, Gali HU, Gao XM, Perchellet JP.
    Int J Cancer; 1993 Dec 02; 55(6):1036-43. PubMed ID: 8253522
    [Abstract] [Full Text] [Related]

  • 3. Ability of the Ca2+ ionophores A23187 and ionomycin to mimic some of the effects of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate on hydroperoxide production, ornithine decarboxylase activity, and DNA synthesis in mouse epidermis in vivo.
    Perchellet EM, Jones D, Perchellet JP.
    Cancer Res; 1990 Sep 15; 50(18):5806-12. PubMed ID: 2118422
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the hydroperoxide response observed in mouse skin treated with tumor promoters in vivo.
    Perchellet EM, Perchellet JP.
    Cancer Res; 1989 Nov 15; 49(22):6193-201. PubMed ID: 2509065
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of action of okadaic acid class tumor promoters on mouse skin.
    Fujiki H, Suganuma M, Yoshizawa S, Nishiwaki S, Winyar B, Sugimura T.
    Environ Health Perspect; 1991 Jun 15; 93():211-4. PubMed ID: 1663450
    [Abstract] [Full Text] [Related]

  • 6. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A.
    Goad DL, Meurer EA, Voelkel EF, Petrou CP, Tashjian AH.
    Endocrinology; 1992 Jun 15; 130(6):3402-10. PubMed ID: 1375901
    [Abstract] [Full Text] [Related]

  • 7. Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo.
    Gali HU, Perchellet EM, Klish DS, Johnson JM, Perchellet JP.
    Int J Cancer; 1992 May 28; 51(3):425-32. PubMed ID: 1592533
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structure-activity relationship within a series of okadaic acid derivatives.
    Nishiwaki S, Fujiki H, Suganuma M, Furuya-Suguri H, Matsushima R, Iida Y, Ojika M, Yamada K, Uemura D, Yasumoto T.
    Carcinogenesis; 1990 Oct 28; 11(10):1837-41. PubMed ID: 2170047
    [Abstract] [Full Text] [Related]

  • 12. Involvement of protein phosphatases in gonadotropin releasing hormone regulated gonadotropin secretion.
    Marantz Y, Reiss N, Przedecki F, Naor Z.
    Mol Cell Endocrinol; 1995 Apr 28; 111(1):7-11. PubMed ID: 7649355
    [Abstract] [Full Text] [Related]

  • 13. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on insulin release from rat pancreatic islets.
    Tamagawa T, Iguchi A, Uemura K, Miura H, Nonogaki K, Ishiguro T, Sakamoto N.
    Endocrinol Jpn; 1992 Jun 28; 39(3):325-9. PubMed ID: 1330503
    [Abstract] [Full Text] [Related]

  • 14. Okadaic acid and dinophysistoxin-1, non-TPA-type tumor promoters, stimulate prostaglandin E2 production in rat peritoneal macrophages.
    Ohuchi K, Tamura T, Ohashi M, Watanabe M, Hirasawa N, Tsurufuji S, Fujiki H.
    Biochim Biophys Acta; 1989 Sep 04; 1013(1):86-91. PubMed ID: 2506933
    [Abstract] [Full Text] [Related]

  • 15. Regulation of mammalian ribonucleotide reductase by the tumor promoters and protein phosphatase inhibitors okadaic acid and calyculin A.
    Hurta RA, Wright JA.
    Biochem Cell Biol; 1992 Sep 04; 70(10-11):1081-7. PubMed ID: 1338411
    [Abstract] [Full Text] [Related]

  • 16. Elevation of transforming growth factor-alpha mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis.
    Kiguchi K, Beltrán LM, You J, Rho O, DiGiovanni J.
    Mol Carcinog; 1995 Apr 04; 12(4):225-35. PubMed ID: 7727044
    [Abstract] [Full Text] [Related]

  • 17. Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1'-acetoxychavicol acetate.
    Nakamura Y, Murakami A, Ohto Y, Torikai K, Tanaka T, Ohigashi H.
    Cancer Res; 1998 Nov 01; 58(21):4832-9. PubMed ID: 9809987
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of jun family gene expression by the tumor promoter okadaic acid.
    Schönthal A, Alberts AS, Frost JA, Feramisco JR.
    New Biol; 1991 Oct 01; 3(10):977-86. PubMed ID: 1662987
    [Abstract] [Full Text] [Related]

  • 19. Augmentation of retinoic acid-induced granulocytic differentiation in HL-60 leukemia cells by serine/threonine protein phosphatase inhibitors.
    Morita K, Nishikawa M, Kobayashi K, Deguchi K, Ito M, Nakano T, Shima H, Nagao M, Kuno T, Tanaka C.
    FEBS Lett; 1992 Dec 21; 314(3):340-4. PubMed ID: 1334850
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effects of 12-O-tetradecanoylphorbol-13-acetate and dexamethasone on de novo synthesis of histidine decarboxylase in mouse mastocytoma P-815 cells.
    Kawai H, Ohgoh M, Emoto S, Ohmori E, Imanishi N, Yatsunami K, Ichikawa A.
    Biochim Biophys Acta; 1992 Jan 13; 1133(2):172-8. PubMed ID: 1310050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.